Catalyst Wire Dossier Catalyst Wire Dossier

Mezagitamab

mezagitamab · Takeda Pharmaceutical Company
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Mezagitamab, covering 2026-01-26 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition [Phase 3]

See pricing